Stryker Corporation $SYK Shares Acquired by Harbor Investment Advisory LLC

Harbor Investment Advisory LLC lifted its holdings in shares of Stryker Corporation (NYSE:SYK) by 4.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,155 shares of the medical technology company’s stock after buying an additional 336 shares during the period. Harbor Investment Advisory LLC’s holdings in Stryker were worth $3,226,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in SYK. Brighton Jones LLC boosted its position in shares of Stryker by 15.4% during the fourth quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock worth $1,643,000 after buying an additional 609 shares during the period. Gotham Asset Management LLC boosted its position in shares of Stryker by 139.8% during the fourth quarter. Gotham Asset Management LLC now owns 4,251 shares of the medical technology company’s stock worth $1,531,000 after buying an additional 2,478 shares during the period. Nomura Holdings Inc. boosted its position in shares of Stryker by 220.2% during the fourth quarter. Nomura Holdings Inc. now owns 15,925 shares of the medical technology company’s stock worth $5,734,000 after buying an additional 10,951 shares during the period. ProShare Advisors LLC boosted its position in shares of Stryker by 12.3% during the fourth quarter. ProShare Advisors LLC now owns 51,940 shares of the medical technology company’s stock worth $18,701,000 after buying an additional 5,686 shares during the period. Finally, Rafferty Asset Management LLC boosted its position in shares of Stryker by 11.9% during the fourth quarter. Rafferty Asset Management LLC now owns 38,909 shares of the medical technology company’s stock worth $14,009,000 after buying an additional 4,134 shares during the period. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Stryker Price Performance

NYSE SYK opened at $383.32 on Friday. The stock has a market capitalization of $146.55 billion, a P/E ratio of 50.77, a P/E/G ratio of 2.80 and a beta of 0.93. Stryker Corporation has a 1 year low of $329.16 and a 1 year high of $406.19. The business’s fifty day moving average is $388.98 and its two-hundred day moving average is $379.65. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.06 and a current ratio of 1.78.

Stryker (NYSE:SYK) last posted its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.07 by $0.06. The company had revenue of $6.02 billion for the quarter, compared to analysts’ expectations of $5.92 billion. Stryker had a return on equity of 23.94% and a net margin of 12.25%.The firm’s revenue was up 11.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.81 earnings per share. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. On average, research analysts forecast that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be issued a $0.84 dividend. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $3.36 annualized dividend and a dividend yield of 0.9%. Stryker’s dividend payout ratio is currently 44.50%.

Insider Buying and Selling at Stryker

In other Stryker news, insider Viju Menon sold 500 shares of the business’s stock in a transaction on Monday, August 25th. The shares were sold at an average price of $390.61, for a total transaction of $195,305.00. Following the sale, the insider directly owned 12,511 shares of the company’s stock, valued at $4,886,921.71. The trade was a 3.84% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Ronda E. Stryker sold 200,000 shares of the business’s stock in a transaction on Wednesday, August 6th. The shares were sold at an average price of $376.45, for a total transaction of $75,290,000.00. Following the sale, the director directly owned 3,222,108 shares in the company, valued at approximately $1,212,962,556.60. This trade represents a 5.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. 5.90% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several brokerages recently commented on SYK. Truist Financial set a $415.00 target price on Stryker and gave the stock a “hold” rating in a report on Monday, August 4th. Needham & Company LLC boosted their target price on Stryker from $442.00 to $448.00 and gave the stock a “buy” rating in a report on Friday, August 1st. Evercore ISI boosted their target price on Stryker from $390.00 to $415.00 and gave the stock an “outperform” rating in a report on Tuesday, July 8th. BTIG Research reissued a “buy” rating on shares of Stryker in a report on Monday, July 14th. Finally, Wells Fargo & Company boosted their target price on Stryker from $435.00 to $445.00 and gave the stock an “overweight” rating in a report on Friday, August 1st. Fourteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, Stryker currently has a consensus rating of “Moderate Buy” and a consensus price target of $431.42.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.